Home-treatment of deep vein thrombosis in patients with cancer

Haematologica

Volumn 90, Issue 2, 2005, Pages 220-224

  Ageno, Walter ^a,c   Grimwood, Rebecca ^b   Limbiati, Sara ^a   Dentali, Francesco ^a   Steidl, Luigi ^a   Wells, Philip S ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OSPEDALE DI CIRCOLO   (Italy)

Author keywords

Cancer; Home treatment; Venous thromboembolism

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; NARCOTIC AGENT; WARFARIN;

AGE; BLEEDING; BREAST CANCER; CANCER LOCALIZATION; CANCER PAIN; CANCER PATIENT; CANCER STAGING; CLINICAL PRACTICE; DEEP VEIN THROMBOSIS; DIGESTIVE SYSTEM CANCER; DRUG SAFETY; GENDER; HOME CARE; HUMAN; METASTASIS; OUTPATIENT CARE; RECURRENT DISEASE; REVIEW; UROGENITAL TRACT CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HOME CARE SERVICES; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; OUTPATIENTS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 14344257839     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Otten HMMB, Prins MH. Venous thromboembolism and occult malignancy. Thromb Res 2001;102:V187-94.
2. Lee AYY. Treatment of venous thromboembolism in cancer patients. Thromb Res 2001;102:V195-208.
3. Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Buller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol 2000;18:3078-83.
4. Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002;100:3484-8.
5. Koopman MMW, Prandoni P, Piovella F, Ockelford PA, Brandjes DP, van der Meer J, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low molecular weight heparin administered at home. N Engl J Med 1996;334:682-7.
6. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. N Engl J Med 1996;334: 677-81.
7. Harrison L, McGinnis J, Crowther M, Ginsberg J, Hirsh J. Assessment of outpatient treatment of deep vein thrombosis with low molecular weight heparin. Arch Intern Med 1998;158: 2001-3.
8. Wells PS, Kovacs MJ, Bormanis J, Forgie MA, Goudie D, Morrow B, et al. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low molecular weight heparin. Arch Intern Med 1998;158:1809-12.
9. Boccalon H, Elias A, Chale JJ, Cadene A, Gabriel S. Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low molecular weight heparin. Arch Intern Med 2000;160:1769-73.
10. Prandoni P. Antithrombotic strategies in patients with cancer. Thromb Hamost 1997;78:141-4.
11. Ageno W, Steidl L, Marchesi C, Dentali F, Mera V, Squizzato A, et al. Selecting patients for home treatment of deep vein thrombosis: the problem of cancer. Haematologica 2002;87:286-91.
12. Vitale J, Ageno W. Home treatment of cancer patients with deep venous thrombosis. Pathophysiol Haemost Thromb 2003;33 Suppl 1:100.
13. Lee AYY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, et al. Low molecular weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003;349:146-53.